Invivyd (IVVD) Operating Margin (QoQ) (2024 - 2025)

Invivyd (IVVD) Operating Margin (QoQ) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,839.48 Bn 65,839.20 Bn -
2 Nanobiotix 1,914.07 Bn 1,914.01 Bn -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn -
4 BeOne Medicines 468.11 Bn 463.32 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.48 Bn 115.23 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.30 Bn 61.55 Bn 3.31 Bn
7 Belite Bio 62.77 Bn 62.77 Bn -
8 Argenx Se 55.66 Bn 50.47 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.42 Bn 34.41 Bn 959.66 Mn
10 Invivyd 104.03 Mn -122.66 Mn 16.07 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1,099.00
Sep 30, 2025 4,382.00
Jun 30, 2025 2,192.00
Mar 31, 2025 -1,056.00
Dec 31, 2024 53,087.00
Sep 30, 2024 150,521.00